WEX PHARMACEUTICALS IN DISPUTE WITH ASIAN INVESTOR OVER PATENT, DEBENTURES

WEX Pharmaceuticals Inc., whose stock was halted Tuesday on the Toronto market, says it's in a dispute with an Asian investor over debentures and a drug patent. The Vancouver-based firm (TSX:WXI) said Wednesday it's in discussions about unsecured convertible debentures worth $5.1 million US that were issued in June 2004 by subsidiary Wex Medical Ltd. to three investment funds managed by a major Asian financial institution.

Canada.com (http://www.canada.com/businesscentre/story.html?id=d60c01e4-bf80-4281-a0a3-3d3f4ca5f4b9)